NBY 财务： NovaBay Pharmaceuticals Inc AI 分析

Q: 技术分析指标如何适用于 NBY？

根据技术分析，NovaBay Pharmaceuticals Inc 的综合信号为 Strong Buy。NovaBay Pharmaceuticals Inc 有 5 个买入信号，2 个中性信号和 0 个卖出信号。

Q: NBY 的斐波那契回调水平是多少？

NovaBay Pharmaceuticals Inc 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: NovaBay Pharmaceuticals Inc 的 RSI 是多少？

NovaBay Pharmaceuticals Inc 的 RSI 目前为 66.84，表明处于 中立 状态

Q: NovaBay Pharmaceuticals Inc 接下来 12 个月的价格是多少？

NovaBay Pharmaceuticals Inc NBY 接下来 12 个月的价格预计为 $0.867。

Q: NovaBay Pharmaceuticals Inc 预计会涨到多高？

据华尔街分析师称，NovaBay Pharmaceuticals Inc 预计将达到 $0.8925 的高预测值。

主页

股票

NBY

预测

NBY 股票价格预测

NovaBay Pharmaceuticals Inc

$14.77

16.39%

$2.08

收盘价：Jan 16, 16:00:00 GMT-5

$12.91

-12.59%

$-1.85

盘后：Jan 16, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$12.69

开盘价

$12.3

当日区间

$11.91 - $18.4

52周范围

$0.46 - $19.95

交易量

2.7M

平均成交量

1.2M

每股收益（TTM）

-6.62

股息收益率

市值

$1.6B

什么是 NBY？

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for NBY in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $0.867. The lowest target is $0.8584 and the highest is $0.8925. Empower your investment choices with our cutting-edge, data-driven analysis!

NBY 股价预测摘要

NBY的顶级分析师评级

基于 5 位分析师对 NBY 的股票评级，更新于 Aug 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NBY. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NBY is a Buy candidate.

NBY stock price ended at $14.77 on 星期五, after rising 16.39%

On the latest trading day Jan 16, 2026, the stock price of NBY rose by 16.39%, climbing from $12.30 to $14.77. During the session, the stock saw a volatility of 57.00%, with prices oscillating between a daily low of $11.72 and a high of $18.40. Notably, trading volume dropped by 1.7M shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.7M shares were traded, equating to a market value of approximately $1.8B.

NBY 技术面信号

技术面信号摘要

购买信号 5

中性信号 2

卖出信号 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

NBY目前显示5个买入信号和0个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为16.39%。总体而言，技术指标显示中期前景为Strong Buy。

NBY 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 NBY 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 NBY？



NBY 的斐波那契回调水平是多少？



NovaBay Pharmaceuticals Inc 的 RSI 是多少？



NovaBay Pharmaceuticals Inc 接下来 12 个月的价格是多少？



NovaBay Pharmaceuticals Inc 预计会涨到多高？



NovaBay Pharmaceuticals Inc（NBY）价格

NBY 股价走势图